249 related articles for article (PubMed ID: 20586082)
41. Seroprevalence of antibodies to parvovirus B19 among children in Papua New Guinea.
Wildig J; Mueller I; Kiniboro B; Maraga S; Siba P; Cossart Y
Am J Trop Med Hyg; 2007 Aug; 77(2):354-7. PubMed ID: 17690412
[TBL] [Abstract][Full Text] [Related]
42. Discovery and characterization of mammalian endogenous parvoviruses.
Kapoor A; Simmonds P; Lipkin WI
J Virol; 2010 Dec; 84(24):12628-35. PubMed ID: 20943964
[TBL] [Abstract][Full Text] [Related]
43. Novel parvovirus sublineage in the family of Parvoviridae.
Wang F; Wei Y; Zhu C; Huang X; Xu Y; Yu L; Yu X
Virus Genes; 2010 Oct; 41(2):305-8. PubMed ID: 20574720
[TBL] [Abstract][Full Text] [Related]
44. Coinfection of parvovirus b19 with other hepatitis viruses leading to fulminant hepatitis of unfavorable outcome in children.
Dwivedi M; Manocha H; Tiwari S; Tripathi G; Dhole TN
Pediatr Infect Dis J; 2009 Jul; 28(7):649-50. PubMed ID: 19483661
[TBL] [Abstract][Full Text] [Related]
45. Detection of goose and Muscovy duck parvoviruses using polymerase chain reaction-restriction enzyme fragment length polymorphism analysis.
Sirivan P; Obayashi M; Nakamura M; Tantaswasdi U; Takehara K
Avian Dis; 1998; 42(1):133-9. PubMed ID: 9533090
[TBL] [Abstract][Full Text] [Related]
46. First report of human parvovirus 4 detection in Iran.
Asiyabi S; Nejati A; Shoja Z; Shahmahmoodi S; Jalilvand S; Farahmand M; Gorzin AA; Najafi A; Haji Mollahoseini M; Marashi SM
J Med Virol; 2016 Aug; 88(8):1314-8. PubMed ID: 26812938
[TBL] [Abstract][Full Text] [Related]
47. Rodent parvovirus infections.
Jacoby RO; Ball-Goodrich LJ; Besselsen DG; McKisic MD; Riley LK; Smith AL
Lab Anim Sci; 1996 Aug; 46(4):370-80. PubMed ID: 8872986
[TBL] [Abstract][Full Text] [Related]
48. Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT.
Rahiala J; Koskenvuo M; Norja P; Meriluoto M; Toppinen M; Lahtinen A; Väisänen E; Waris M; Vuorinen T; Saarinen-Pihkala U; Lappalainen M; Allander T; Ruuskanen O; Hedman K; Söderlund-Venermo M; Vettenranta K
Bone Marrow Transplant; 2013 Oct; 48(10):1308-12. PubMed ID: 23686097
[TBL] [Abstract][Full Text] [Related]
49. Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors.
Moehler M; Blechacz B; Weiskopf N; Zeidler M; Stremmel W; Rommelaere J; Galle PR; Cornelis JJ
Cancer Gene Ther; 2001 Mar; 8(3):158-67. PubMed ID: 11332986
[TBL] [Abstract][Full Text] [Related]
50. Parvovirus variation for disease: a difference with RNA viruses?
López-Bueno A; Villarreal LP; Almendral JM
Curr Top Microbiol Immunol; 2006; 299():349-70. PubMed ID: 16568906
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma.
Baylis SA; Shah N; Minor PD
J Virol Methods; 2004 Oct; 121(1):7-16. PubMed ID: 15350727
[TBL] [Abstract][Full Text] [Related]
52. Detection of rat parvovirus type 1 and rat minute virus type 1 by polymerase chain reaction.
Wan CH; Bauer BA; Pintel DJ; Riley LK
Lab Anim; 2006 Jan; 40(1):63-9. PubMed ID: 16460590
[TBL] [Abstract][Full Text] [Related]
53. Coping with parvovirus infections in mice: health surveillance and control.
Janus LM; Bleich A
Lab Anim; 2012 Jan; 46(1):14-23. PubMed ID: 22037057
[TBL] [Abstract][Full Text] [Related]
54. Human parvovirus B19 (B19V) infection in systemic sclerosis patients.
Zakrzewska K; Corcioli F; Carlsen KM; Giuggioli D; Fanci R; Rinieri A; Ferri C; Azzi A
Intervirology; 2009; 52(5):279-82. PubMed ID: 19672101
[TBL] [Abstract][Full Text] [Related]
55. [Parvoviruses as pathogenic agents in man].
Tratschin JD; Siegl G
Schweiz Med Wochenschr; 1988 Mar; 118(10):347-53. PubMed ID: 2834818
[TBL] [Abstract][Full Text] [Related]
56. Novel B19-like parvovirus in the brain of a harbor seal.
Bodewes R; Rubio García A; Wiersma LC; Getu S; Beukers M; Schapendonk CM; van Run PR; van de Bildt MW; Poen MJ; Osinga N; Sánchez Contreras GJ; Kuiken T; Smits SL; Osterhaus AD
PLoS One; 2013; 8(11):e79259. PubMed ID: 24223918
[TBL] [Abstract][Full Text] [Related]
57. Pathways of cell infection by parvoviruses and adeno-associated viruses.
Vihinen-Ranta M; Suikkanen S; Parrish CR
J Virol; 2004 Jul; 78(13):6709-14. PubMed ID: 15194745
[No Abstract] [Full Text] [Related]
58. Human parvovirus PARV4 in plasma pools of Chinese origin.
Ma YY; Guo Y; Zhao X; Wang Z; Lv MM; Yan QP; Zhang JG
Vox Sang; 2012 Oct; 103(3):183-5. PubMed ID: 22458565
[TBL] [Abstract][Full Text] [Related]
59. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
60. Increasing porcine PARV4 prevalence with pig age in the U.S. pig population.
Xiao CT; Giménez-Lirola LG; Halbur PG; Opriessnig T
Vet Microbiol; 2012 Dec; 160(3-4):290-6. PubMed ID: 22728123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
